Heart Disease News and Research

Latest Heart Disease News and Research

UAB receives $1.47M NHLBI grant to study red blood cell lesion

Researchers in the University of Alabama at Birmingham (UAB) departments of Pathology, Microbiology and Surgery have received a $1.47 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to study so-called red blood cell lesion, a term given to the potentially harmful changes in red blood cells that have been stored for longer times after collection.

23 Jun 2010

Survey: MegaRed Omega-3 Krill Oil recommended for overall cardiovascular health

With America focused on the future of healthcare, a recent survey provides Americans added confidence in the ability of supplements like MegaRed Omega-3 Krill Oil to support their overall cardiovascular health.

23 Jun 2010

Exercise alone without creatine supplements helps in cardiac rehabilitation

Athletes have been enjoying the benefits of creatine supplements to gain stronger muscles since the 1990s, and the supplement has also proven beneficial among other groups. Could it help cardiac patients regain strength to help with their heart-training workouts as part of rehabilitation? The evidence at this stage suggests not - exercise alone proved a far more powerful tonic for patients in a study out today. The results appear in the journal Clinical Rehabilitation, published by SAGE.

23 Jun 2010

Mice treated with XOMA 052 experiences improvement in measures associated with diabetes: Endocrinology

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced the publication of data from a mouse model of diet-induced obesity in the June, 2010 edition of the journal Endocrinology. The data showed that mice treated with XOMA 052 both prophylactically and therapeutically experienced improvement in measures associated with diabetes and cardiovascular disease including reduction in glycosylated hemoglobin levels, improvement in glucose control, improved beta-cell survival and function, and a reduction in total cholesterol without reduction in high density lipoprotein.

23 Jun 2010

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

23 Jun 2010

Study investigates benefits of filtering blood to create safer approaches to transfusion therapy

Researchers at the University of Rochester Medical Center have discovered yet another reason to filter the foreign white cells from donor blood: The resulting blood product is associated with dramatically fewer cardiopulmonary complications for patients who received a transfusion.

23 Jun 2010

FDA approves Hospira's meropenem for injection, USP (I.V.)

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a carbapenem that belongs to the beta-lactam class of antibiotics, is a generic version of AstraZeneca's Merrem® I.V. Sales of the name-brand product in the United States were approximately $200 million in 2009.

23 Jun 2010

Nuon study confirms potential utility of tranilast as uricosuric agent

Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that results from clinical and preclinical studies demonstrating the ability of tranilast to reduce serum uric acid levels and monosodium urate crystal-induced inflammation - two important risk factors for gout - were presented at The European League Against Rheumatism (EULAR) 2010 Annual European Congress of Rheumatology in Rome, Italy, June 16-19, 2010.

22 Jun 2010

Fructose makes cells mature into fat cells in belly fat, study finds

Fructose, the sugar widely used as high-fructose corn syrup in soft drinks and processed foods, often gets some of the blame for the widespread rise in obesity. Now a laboratory study has found that when fructose is present as children's fat cells mature, it makes more of these cells mature into fat cells in belly fat and less able to respond to insulin in both belly fat and fat located below the skin.

22 Jun 2010

Three leading scientists gather to discuss Improved Strategies for Pre-clinical Cardiac Testing

Three leading scientists in the field of cardiac safety in pre-clinical drug development are gathering to discuss Improved Strategies for Pre-clinical Cardiac Testing in a free webinar on June 23 at 11:00 a.m. EDT, sponsored by the Drug Safety Council.

22 Jun 2010

Beneficial effects of LifeVantage's Protandim on DMD mouse model published in Journal of Dietary Supplements

LifeVantage Corporation, the maker of Protandim®, a patented, science-based solution to oxidative stress, announced today that a peer-reviewed manuscript was published in the Journal of Dietary Supplements examining the beneficial effects of Protandim® on a mouse model of Duchenne Muscular Dystrophy (DMD), an X-linked inherited disease affecting one in 3,500 males.

22 Jun 2010

Nature Rocks, American Heart Association encourage increased physical activity among all Americans

Today Nature Rocks, a national program created to inspire and empower parents to take their families to play, explore and enjoy quality time in nature, announced a collaboration with the American Heart Association's Start! Initiative. Start! encourages increased physical activity among all Americans, emphasizing walking because it's easy, free and has the lowest dropout rate of any form of activity.

22 Jun 2010

Cardiogenesis' shares quoted on newly launched OTCQB market

Cardiogenesis Corporation today announced that its shares are now being quoted on the newly launched OTCQB market. Launched in April 2010, the OTCQB is a new market tier for OTC-traded U.S. companies that are registered and reporting with the Securities and Exchange Commission.

22 Jun 2010

NIH, Wellcome Trust partner to support population-based genetic studies of disorders, communicable diseases in Africa

The National Institutes of Health, an agency of the U.S. Department of Health and Human Services, and the Wellcome Trust, a global charity based in London, today announced a partnership to support population-based genetic studies in Africa of common, non-communicable disorders such as heart disease and cancer, as well as communicable diseases such as malaria.

22 Jun 2010

Regulus Therapeutics, sanofi-aventis partner to develop and commercialize microRNA therapeutics

Regulus Therapeutics Inc. and sanofi-aventis announced today that they have entered into a global, strategic alliance to discover, develop, and commercialize microRNA therapeutics. The alliance represents the largest microRNA partnership formed to date, valued at potentially over $750 million, and includes a $25 million upfront fee, a $10 million future equity investment subject to mutual agreement on company valuation, and annual research support for three years with the option to extend two additional years.

22 Jun 2010

Metabolic syndrome can negatively affect donor's kidney function outcome, study finds

People who donate one of their kidneys experience faster deterioration of their other kidney if they have the metabolic syndrome at the time of donation, a new study finds. The results will be presented Sunday at The Endocrine Society's 92nd Annual Meeting in San Diego.

22 Jun 2010

Improving health care for Saskatchewan patients remains a challenge: HQC report

In October 2008 the province's Health Quality Council released its first "state of health care quality" report, called Quality Insight. Key messages in that inaugural report were that limited access to timely data and the absence of an electronic health record were making it hard for HQC, health providers, and system leaders to improve health care for Saskatchewan patients.

22 Jun 2010

Insurance cover in "passive war" environment saves reforestation expert

Conflicts and wars not only take their toll on human lives, but also on the local environment. Whilst much publicity is focused on International efforts to help rebuild Afghanistan's economy and social structures, less well known is the - often voluntary - work going on to rebuild the environment, part of which involves the planting of millions of trees, as a more green environment helps to improve the dusty landscape damaged by years of fighting. More greenery also means cleaner air.

22 Jun 2010

Gardner Family Health Network to deploy NextGen Ambulatory EHR, Practice Management, QSI Dental System

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced an agreement with Gardner Family Health Network to deploy NextGen® Ambulatory EHR and NextGen® Practice Management, as well as the QSI Dental System. Gardner is the 42nd health center in California to partner with NextGen Healthcare.

22 Jun 2010

Six Rio South Texas hospitals among nation's top 5%

Successful regional economic development has to focus on more than tax incentives, skilled labor pools and transportation infrastructure. In considering possible locations for starting or expanding operations, corporations look closely at quality of life issues such as the availability of excellent healthcare. And Rio South Texas has a healthy quality of life outlook, with six of the nation's safest hospitals among its offerings.

22 Jun 2010

Heart Disease News and Research

Latest Heart Disease News and Research

UAB receives $1.47M NHLBI grant to study red blood cell lesion

Survey: MegaRed Omega-3 Krill Oil recommended for overall cardiovascular health

Exercise alone without creatine supplements helps in cardiac rehabilitation

Mice treated with XOMA 052 experiences improvement in measures associated with diabetes: Endocrinology

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Study investigates benefits of filtering blood to create safer approaches to transfusion therapy

FDA approves Hospira's meropenem for injection, USP (I.V.)

Nuon study confirms potential utility of tranilast as uricosuric agent

Fructose makes cells mature into fat cells in belly fat, study finds

Three leading scientists gather to discuss Improved Strategies for Pre-clinical Cardiac Testing

Beneficial effects of LifeVantage's Protandim on DMD mouse model published in Journal of Dietary Supplements

Nature Rocks, American Heart Association encourage increased physical activity among all Americans

Cardiogenesis' shares quoted on newly launched OTCQB market

NIH, Wellcome Trust partner to support population-based genetic studies of disorders, communicable diseases in Africa

Regulus Therapeutics, sanofi-aventis partner to develop and commercialize microRNA therapeutics

Metabolic syndrome can negatively affect donor's kidney function outcome, study finds

Improving health care for Saskatchewan patients remains a challenge: HQC report

Insurance cover in "passive war" environment saves reforestation expert

Gardner Family Health Network to deploy NextGen Ambulatory EHR, Practice Management, QSI Dental System

Six Rio South Texas hospitals among nation's top 5%

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Heart Disease News and Research

Latest Heart Disease News and Research

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Newsletters you may be interested in